Replies to post #13041 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

if GTC's enhanced ADCC turns out to be something of great consequence

I get the impression this is the case. I was told the problems with partnering revolved around the platform issue.

One of the problems with the regulatory process as it now exists, is counter to all other forms of technology,...improvements are twarted